Plakophilin 2 Gene Therapy Prevents and Rescues Arrhythmogenic Right Ventricular Cardiomyopathy in a Mouse Model Harboring Patient Genetics

Investigators generated a mouse model harboring a plakophilin 2 mutation affecting RNA splicing, recapitulating arrhythmogenic right ventricular cardiomyopathy features and sudden death starting at four weeks.